Cohere Health Secures $90 Million in Series C
Cohere Health, a Boston, MA-based provider of clinical intelligence solutions for health plans and risk-bearing providers, has secured $90 million in Series C funding.
Cohere Health, a Boston, MA-based provider of clinical intelligence solutions for health plans and risk-bearing providers, has secured $90 million in Series C funding.
Investors
The round was led by Temasek, with participation from Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners.
Cohere Health Use of Funds
The company will use the funding to scale its Cohere Unify platform, expand into new clinical use cases, and enhance its AI-driven product portfolio.
About Cohere Health
Founded in 2019 by Siva Namasivayam and Duncan Reece, Cohere Health is a clinical intelligence company delivering AI-powered prior authorization solutions that streamline access to quality care by improving collaboration between physicians and health plans. Its flagship platform, Cohere Unify, modernizes utilization management by personalizing provider workflows and enabling real-time data engagement. Cohere handles over 12 million authorization requests annually and serves more than 600,000 providers across the U.S. Headquartered in Boston, Massachusetts, the company's mission is to help people receive the right care at the right time, in the right place, and with the right value.
Funding Details
Company: Cohere Health
Raised: $90.0M
Round: Series C
Funding Date: May 2025
Lead Investor: Temasek
Additional Investors: Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, Polaris Partners
Company Website: https://www.coherehealth.com/
Software Category: Healthcare AI / Clinical Intelligence
